Industry

AstraZeneca

Global biopharmaceutical company with R&D in respiratory, immunology, oncology, and rare disease

Location: Cambridge, UK
Website
1 model(1 RNA, 1 Protein)

Models (1)

ZeroFold

University of Cambridge / AstraZeneca

Released March 24, 2026

A transformer that predicts protein-RNA binding affinity from Boltz-2 pre-structural embeddings via cross-modal attention, without requiring predicted structures.

RNAProtein